Idiopathic pulmonary arterial hypertension: Current state of play and new treatment modalities

J. Simon R. Gibbs, Craig S. Broberg, Michael A. Gatzoulis

    Research output: Contribution to journalArticle

    8 Scopus citations


    Research in pulmonary hypertension has led to exciting advances over the last decade, both in terms of understanding aetiology and expanding treatment options. This review highlights the current approach to classification and disease management. In particular, we review the significant data and recommendations on the use of prostacyclin analogues, endothelin receptor antagonists, phosphodiesterase inhibitors and drug combinations.

    Original languageEnglish (US)
    Pages (from-to)7-10
    Number of pages4
    JournalInternational Journal of Cardiology
    Issue numberSUPPL. 1
    StatePublished - Dec 1 2004



    • Phosphodiesterase
    • Prostacyclin
    • Pulmonary hypertension

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine

    Cite this